A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males

Clinical trial NCT05396235 · COMPLETED

Trial details

NCT number: NCT05396235
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Males

Start date: 2022-08-03
Primary completion: 2022-12-24
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.